Pages with the fewest revisions

From OncoWiki
Jump to navigationJump to search

Showing below up to 50 results in range #1 to #50.

View (previous 50 | ) (20 | 50 | 100 | 250 | 500)

  1. Cytarabine Idarubicin Vorinostat induction‏‎ (1 revision)
  2. VDT-PACE‏‎ (1 revision)
  3. R-MPV‏‎ (1 revision)
  4. Cisplatin + Etoposide + RT → Docetaxel‏‎ (1 revision)
  5. Flu Bu ATG for Haplo‏‎ (1 revision)
  6. Weekly Carboplatin + Paclitaxel + RT → Carboplatin + Paclitaxel‏‎ (1 revision)
  7. BeGeV‏‎ (1 revision)
  8. Cytarabine Idarubicin Vorinostat consolidation‏‎ (1 revision)
  9. Dacarbazine + Cisplatin + Carmustine‏‎ (2 revisions)
  10. ECF + surgery + ECF‏‎ (2 revisions)
  11. FCR‏‎ (2 revisions)
  12. FUFOX + Cetuximab‏‎ (2 revisions)
  13. Gemcitabine + Docetaxel‏‎ (2 revisions)
  14. HyperCVADHDMTX-AraC‏‎ (2 revisions)
  15. Lenalidomide‏‎ (2 revisions)
  16. MP‏‎ (2 revisions)
  17. 5-FU + Cisplatin + RT + Surgery‏‎ (2 revisions)
  18. Octreotide‏‎ (2 revisions)
  19. ADOC‏‎ (2 revisions)
  20. Plerixafor and G-CSF‏‎ (2 revisions)
  21. Azacitidine‏‎ (2 revisions)
  22. Rituximab, Bendamustine, Bortezomib‏‎ (2 revisions)
  23. Breast Cancer‏‎ (2 revisions)
  24. Temozolomide + IFN‏‎ (2 revisions)
  25. CMV‏‎ (2 revisions)
  26. VMPT‏‎ (2 revisions)
  27. Carboplatin + Paclitaxel‏‎ (2 revisions)
  28. Cisplatin + 5-FU‏‎ (2 revisions)
  29. Cisplatin + RT‏‎ (2 revisions)
  30. Dactinomycin‏‎ (2 revisions)
  31. EP‏‎ (2 revisions)
  32. FLAG‏‎ (2 revisions)
  33. Fludarabine‏‎ (2 revisions)
  34. Gemcitabine + Erlotinib‏‎ (2 revisions)
  35. ICE‏‎ (2 revisions)
  36. Lenalidomide + Rituximab‏‎ (2 revisions)
  37. MPT‏‎ (2 revisions)
  38. 5-FU + Cisplatin + Vinblastine + RT + Surgery‏‎ (2 revisions)
  39. Ovarian Epithelial Cancer‏‎ (2 revisions)
  40. AI‏‎ (2 revisions)
  41. Postremission High Dose Cytarabine‏‎ (2 revisions)
  42. BEP‏‎ (2 revisions)
  43. CAF‏‎ (2 revisions)
  44. Temozolomide + IL-2 + IFN + GM-CSF‏‎ (2 revisions)
  45. CNOP‏‎ (2 revisions)
  46. VNCOP-B‏‎ (2 revisions)
  47. Carboplatin + Paclitaxel + Bevacizumab‏‎ (2 revisions)
  48. Cisplatin + 5-FU + RT‏‎ (2 revisions)
  49. Cisplatin + Topotecan‏‎ (2 revisions)
  50. Dasatinib‏‎ (2 revisions)

View (previous 50 | ) (20 | 50 | 100 | 250 | 500)